Increased liver ceramide levels have also been associated with the development of hepatic insulin resistance due to ceramides can attenuate insulin signaling in liver and skeletal muscle by reducing GLUT4 translocation and glucose uptake [54]. The gene discussed is INS; the disease is Insulin resistance.